With the increasing costs of drug development, the elimination of problematic candidates early in a program is more important than ever,” said Clanton. “The acquisition of a Sophion QPatch-II ...

SPARC share price plunged 20% following poor Phase 2 trial outcomes for SCD-044. The stock peaked at ₹186 but fell to ₹156.50 during trading on the BSE.

Anna Moberg, Senior Manager and Project Manager, Cytiva, added: “The ability of Nuclera’s eProtein Discovery to accelerate protein production and purification complements Cytiva’s Biacore SPR ...

CAMBRIDGE, England & MARLBOROUGH, Mass., May 28, 2025--Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ System, has ...

<p>One of the first and most promising uses scientists envision for the rapidly evolving technology of quantum computing is a new approach to drug development. A quantum computer could, in theory ...

As proof of the technology’s potential, a group of researchers published a paper in Nature Biotechnology earlier this year showing how they could use a small-scale quantum computer designed by ...

Additionally, pharmaceutical companies often study biomarkers during the drug development process. Pathos says that its AI model will enable researchers to discover new biomarkers more efficiently.

GSK Plc and iTeos Therapeutics ended the development of an experimental lung cancer drug, the latest in a series of setbacks for a new generation of immunotherapy medicines.

Well, Alex, it's a fascinating conversation, super interesting in what's going on in this oncology drug development, and I think it's fascinating and important as well.

Continuous process improvement can benefit all aspects of life — from personal New Year’s resolutions to complex drug development. In a world where two-thirds of planned improvement ...